Wuxi works with Mayo Clinic to expand PDX mouse model collection
Wuxi Pharmatech has agreed to licence patient-derived xenograft (PDX) mouse models from the Mayo Clinic's Center for Individualized Medicine.
Archives for November 6, 2013
Close-out Letter a 'pivotal milestone' for AMRI's troubled Burlington plant
Persistence, endurance and a steadfast focus has led to AMRI receiving a close-out letter for its long suffering Burlington, Massachusetts facility, the company says.
Chemport confirms it will keep supplying Amarin with Vascepa API
A third Amarin supplier has confirmed it will continue to supply the firm with pharma-grade omega-3 despite a US FDA panel recommending against a label extension for the heart pill Vascepa.
Novartis confirms facility closure plan with 443 jobs set to go
Novartis has confirmed it is closing a UK facility as part of a global R&D review but remains silent on rumours specific business units will be divested.
US FDA looks to speed placement of more inspectors in China
The US FDA told us that China has “taken longer than FDA had hoped” in approving the visas of new FDA inspectors that would more than double the agency's presence in China.
Quintiles paid $146.5M for CRO Novella, SEC filing shows
CRO Quintiles said that it paid $146.5M in cash for oncology and device CRO Novella Clinical.